Halozyme Therapeutics shares owned by Aigen Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Aigen Investment Management
from 13F filings
Historical chart of Aigen Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Aigen Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Aigen Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $978k | 24k | 40.68 |
| 2023-12-31 | $331k | 8.9k | 36.96 |
| 2023-09-30 | $251k | 6.6k | 38.20 |
| 2022-06-30 | $1.0M | 23k | 44.01 |
| 2022-03-31 | $1.0M | 25k | 39.89 |
| 2021-12-31 | $486k | 15k | 33.46 |
| 2021-09-30 | $481k | 12k | 40.68 |
| 2021-03-31 | $859k | 21k | 41.71 |
| 2020-12-31 | $1.4M | 33k | 42.71 |
| 2020-09-30 | $1.3M | 50k | 26.28 |
| 2020-06-30 | $219k | 8.2k | 26.83 |
| 2020-03-31 | $53k | 3.0k | 17.92 |
| 2019-12-31 | $719k | 41k | 17.74 |
More positions owned by Aigen Investment Management
View all positions for Aigen Investment Management